Document is current

Development and validation of a reversed-phase HPLC method for the simultaneous determination of alogliptin and pioglitazone in combined tablet dosage form

Crossref DOI link: https://doi.org/10.53430/ijcpru.2026.7.1.0041

Published Online: 2026-07-31

Update policy: https://doi.org/10.53430/osj.ourcrossmarkpolicy